Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.74
MRIC's Cash-to-Debt is ranked lower than
67% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. MRIC: 0.74 )
Ranked among companies with meaningful Cash-to-Debt only.
MRIC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.74 Max: N/A
Current: 0.74
Equity-to-Asset -0.10
MRIC's Equity-to-Asset is ranked lower than
94% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. MRIC: -0.10 )
Ranked among companies with meaningful Equity-to-Asset only.
MRIC' s Equity-to-Asset Range Over the Past 10 Years
Min: -7.21  Med: -0.53 Max: -0.01
Current: -0.1
-7.21
-0.01
Piotroski F-Score: 3
Altman Z-Score: -18.28
Beneish M-Score: -4.11
WACC vs ROIC
6.85%
-1507.45%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -130.27
MRIC's Operating Margin % is ranked lower than
81% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.84 vs. MRIC: -130.27 )
Ranked among companies with meaningful Operating Margin % only.
MRIC' s Operating Margin % Range Over the Past 10 Years
Min: -356.5  Med: -155.11 Max: -61.86
Current: -130.27
-356.5
-61.86
Net Margin % -140.37
MRIC's Net Margin % is ranked lower than
80% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. MRIC: -140.37 )
Ranked among companies with meaningful Net Margin % only.
MRIC' s Net Margin % Range Over the Past 10 Years
Min: -354.22  Med: -180.26 Max: -116.21
Current: -140.37
-354.22
-116.21
ROA % -98.21
MRIC's ROA % is ranked lower than
86% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.21 vs. MRIC: -98.21 )
Ranked among companies with meaningful ROA % only.
MRIC' s ROA % Range Over the Past 10 Years
Min: -548.58  Med: -99.33 Max: -42.57
Current: -98.21
-548.58
-42.57
ROC (Joel Greenblatt) % -1593.91
MRIC's ROC (Joel Greenblatt) % is ranked lower than
87% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 4.32 vs. MRIC: -1593.91 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MRIC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1823.15  Med: -777.6 Max: -262.01
Current: -1593.91
-1823.15
-262.01
3-Year Revenue Growth Rate -8.70
MRIC's 3-Year Revenue Growth Rate is ranked lower than
77% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 4.70 vs. MRIC: -8.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MRIC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -44.2  Med: -29 Max: -8.7
Current: -8.7
-44.2
-8.7
3-Year EBITDA Growth Rate -16.70
MRIC's 3-Year EBITDA Growth Rate is ranked lower than
83% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 5.60 vs. MRIC: -16.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MRIC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -54.3  Med: -31.5 Max: 9.2
Current: -16.7
-54.3
9.2
3-Year EPS without NRI Growth Rate -15.20
MRIC's 3-Year EPS without NRI Growth Rate is ranked lower than
73% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. MRIC: -15.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MRIC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55.9  Med: -30.8 Max: -9.3
Current: -15.2
-55.9
-9.3
GuruFocus has detected 3 Warning Signs with MRI Interventions Inc $MRIC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MRIC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with MRIC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare: » details
MRI Interventions Inc is a medical device company. It develops & commercializes technology enabling physicians to see inside the brain & heart using direct, intra-procedural MRI guidance while performing minimally invasive surgical procedures.

MRI Interventions Inc is a medical device company incorporated in the state of Delaware in March 1998. The Company is engaged in the development and commercialization of technology that enables physicians to see inside the brain and heart using direct, intra-procedural magnetic resonance imaging ("MRI") guidance while performing minimally invasive surgical procedures. The Company's ClearPoint system, an integrated system comprised of reusable and disposable products, is designed to allow minimally invasive procedures in the brain to be performed in an MRI suite. The Company's ClearTrace system is a product candidate under development that is designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The Company faces competitions from companies including Medtronic plc, St. Jude Medical Inc. and Biosense Webster Inc., a division of Johnson & Johnson. The Company is subject to extensive regulation by the FDA and various other federal, state and foreign governmental authorities.

Ratios

vs
industry
vs
history
PS Ratio 2.29
MRIC's PS Ratio is ranked higher than
62% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 3.34 vs. MRIC: 2.29 )
Ranked among companies with meaningful PS Ratio only.
MRIC' s PS Ratio Range Over the Past 10 Years
Min: 0.86  Med: 11.8 Max: 22.37
Current: 2.29
0.86
22.37
Current Ratio 2.02
MRIC's Current Ratio is ranked lower than
58% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.28 vs. MRIC: 2.02 )
Ranked among companies with meaningful Current Ratio only.
MRIC' s Current Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.85 Max: 2.38
Current: 2.02
0.11
2.38
Quick Ratio 1.43
MRIC's Quick Ratio is ranked lower than
58% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. MRIC: 1.43 )
Ranked among companies with meaningful Quick Ratio only.
MRIC' s Quick Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.66 Max: 1.98
Current: 1.43
0.04
1.98
Days Inventory 237.31
MRIC's Days Inventory is ranked lower than
77% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 124.59 vs. MRIC: 237.31 )
Ranked among companies with meaningful Days Inventory only.
MRIC' s Days Inventory Range Over the Past 10 Years
Min: 237.31  Med: 315.63 Max: 613.48
Current: 237.31
237.31
613.48
Days Sales Outstanding 54.98
MRIC's Days Sales Outstanding is ranked higher than
69% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 67.79 vs. MRIC: 54.98 )
Ranked among companies with meaningful Days Sales Outstanding only.
MRIC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.11  Med: 51.24 Max: 96.77
Current: 54.98
32.11
96.77
Days Payable 213.64
MRIC's Days Payable is ranked higher than
90% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. MRIC: 213.64 )
Ranked among companies with meaningful Days Payable only.
MRIC' s Days Payable Range Over the Past 10 Years
Min: 128.15  Med: 283.67 Max: 2246.2
Current: 213.64
128.15
2246.2

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -35.30
MRIC's 3-Year Average Share Buyback Ratio is ranked lower than
89% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. MRIC: -35.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MRIC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -105.2  Med: -51.3 Max: -23.9
Current: -35.3
-105.2
-23.9

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.19
MRIC's Price-to-Median-PS-Value is ranked higher than
94% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. MRIC: 0.19 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MRIC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.13  Med: 1 Max: 1.77
Current: 0.19
0.13
1.77
Earnings Yield (Greenblatt) % -35.35
MRIC's Earnings Yield (Greenblatt) % is ranked lower than
83% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. MRIC: -35.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MRIC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -64.37  Med: 0 Max: 769.25
Current: -35.35
-64.37
769.25

More Statistics

Revenue (TTM) (Mil) $5.75
EPS (TTM) $ -2.83
Beta0.10
Short Percentage of Float0.00%
52-Week Range $1.99 - 20.00
Shares Outstanding (Mil)3.62
» More Articles for MRIC

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
MRI Interventions, Inc. :MRIC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
MRI Interventions, Inc. :MRIC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
MRI INTERVENTIONS, INC. Financials Mar 15 2017
MRI INTERVENTIONS, INC. Files SEC form 10-K, Annual Report Mar 09 2017
MRI INTERVENTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 28 2017
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results Feb 28 2017
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results Feb 28 2017
MRI Interventions, Inc. Fourth Quarter and Full Year 2016 Financial Results Conference Call and... Feb 21 2017
MRI Interventions, Inc. Fourth Quarter and Full Year 2016 Financial Results Conference Call and... Feb 21 2017
MRI Interventions Selects Pacific Mercantile Bank as its Primary Banking Relationship Feb 02 2017
MRI Interventions, Inc. Announces Year-End Update, Including 2016 Fourth Quarter and Full Year... Jan 24 2017
MRI Interventions, Inc. Announces Year-End Update, Including 2016 Fourth Quarter and Full Year... Jan 24 2017
MRI Interventions’ ClearPoint® Surpasses Single-Year Milestone of 500 Procedures in 2016 Jan 04 2017
MRI Interventions' ClearPoint(R) Surpasses Single-Year Milestone of 500 Procedures in 2016 Jan 04 2017
MRI Interventions' ClearPoint(R) Neuro Navigation System to be Utilized in Medicenna Therapeutics'... Dec 19 2016
MRI Interventions' ClearPoint(R) Neuro Navigation System Utilized in Voyager Therapeutics' VY-AADC01... Dec 08 2016
MRI Interventions' ClearPoint(R) Neuro Navigation System to be Exhibited at Pediatric Neurosurgical... Dec 05 2016
MRI Interventions' ClearPoint(R) Neuro Navigation System to be Featured at the American Epilepsy... Nov 28 2016
MRI INTERVENTIONS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
MRI Interventions, Inc. :MRIC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016 Nov 07 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)